Enigma Diagnostics appoints Professor Christopher Lowe as non-executive director
Enigma diagnostics, a Life Sciences company developing rapid molecular diagnostics systems, announced the appointment of Professor Christopher Lowe as Non-executive Director. Professor Lowe is Director of the Institute of biotechnology at the University of Cambridge. He is a Fellow of the Royal Academy of Engineering, the Institute of Physics and the Royal Society of chemistry.
Over the past 30 years, Prof. Lowe has focused on the development of pharmaceuticals, fine chemicals and diagnostics based on a highly inter- and multi-disciplinary approach. His approach combines aspects of biochemistry, microbiology, chemistry, electrochemistry, physics, electronics, medicine and chemical engineering, and from pure science to strategic applied science to the development of commercial applications.
Topics
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.